Alnylam to Present at TD Cowen Healthcare Conference
Event summary
- Alnylam management to present company overview on March 2, 2026, at 9:10 am ET.
- Live audio webcast available on Alnylam's Investors section.
- Replay to be available within 48 hours post-event.
- Presentation part of TD Cowen 46th Annual Healthcare Conference.
The big picture
Alnylam's presentation at the TD Cowen Healthcare Conference comes as the company executes its Alnylam 2030 strategy, aiming to scale impact and transform human health through RNAi therapeutics. The event provides a platform to showcase its pipeline and global reach, which are critical in a competitive biopharmaceutical landscape. Investors will be watching for updates on pipeline progress and strategic positioning.
What we're watching
- Pipeline Progress
- How Alnylam's expanding pipeline will impact its Alnylam 2030 strategy.
- Market Positioning
- Whether Alnylam can sustain its leadership in RNAi therapeutics amid competition.
- Investor Sentiment
- The pace at which investor confidence may shift based on conference insights.